Abiopharma

🔍 Doherty John N. (Executive)

Company: Butterfly Network, Inc. (BFLY)

Report Date: 2025-12-08

Detailed Transactions and Holdings:

• Acquired 863,247 shares of Class A Common Stock (Direct)
  Date: 2025-12-08 | Code: A | equity_swap_involved: 0 | shares_owned_after: 863,247.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 431,623 shares of Class A Common Stock (Direct)
  Date: 2025-12-08 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,294,870.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A Common Stock ("Common Stock") upon vesting. One-third of the RSUs underlying this grant vest on December 8, 2026, and the remainder shall vest on a pro rata annual basis over the next two years, subject to the Reporting Person's continued service through the applicable vesting date.
• F2: Consists of performance-based RSUs. The RSUs underlying this grant shall vest as follows: (i) one-third shall vest upon the achievement of a price for the Common Stock equal to or exceeding $3.00 per share, (ii) one-third shall vest upon the achievement of a price for the Common Stock equal to or exceeding $4.50 per share and (iii) one-third shall vest upon the achievement of a price for the Common Stock equal to or exceeding $6.00 per share. In each case, the closing stock price for 20 consecutive trading days must equal or exceed the share price targets, provided such share price is achieved prior to December 8, 2030, subject to the Reporting Person's continued service through the applicable vesting date.